07:20

Hepatocellular Carcinoma Cancer Inflammation, Immunity and Senescence Michael Karin AACR IO 2025

04:31

AACR 2025 IO: Unlocking Desmoplastic Melanoma’s Secrets with Kari Kendra, MD, PhD - Ohio State

02:09

AACR 2025 IO: The Future of Immunotherapy Unveiled in LA with Antoni Ribas, MD UCLA Cancer Center

04:25

Steve Jobs Death, could we save him in 2025 from pancreatic cancer?

02:35

Can MRI Safely Skip Prostate Biopsies? 3-Year Study Results

01:31

FDA Approves Enhertu for HR+/HER2-low Breast Cancer: Key Trial Results & Insights

01:27

FDA Approves Deciphera Vimseltinib / Romvimza for symptomatic tenosynovial giant cell tumor (TGCT)

02:04

Enfortumab Vedotin (EV-302) + Pembrolizumab vs. Chemo for la/mUC Phase 3 Update ASCO GU 2025 Powles

02:06

Nivolumab CheckMate-274 Extended Results ASCO GU 2025 Continued Benefit in MIBC

01:28

Durvalumab / Imfinzi (NIAGRA Trial) Defies Odds in MIBC Survival Benefits Beyond Complete Response

03:58

TALZENNA / Talazoparib + Enzalutamide Shocking mCRPC Survival. Is it The New Gold Standard? ASCO GU

02:26

What Is Cancer? What Causes Cancer & How Is It Treated?

01:36

FDA Approves Adcetris / brentuximab vedotin + lenalidomide & rituximab in relapsed or refractory LBC

01:51

FDA Approves Mirdametinib / Gomekli for NF1-PN: A Comprehensive Data Overview

01:03

CAR-T Cell Therapy is not Revolutionizing the Fight Against GI Cancers, Why? 17 Trials from ASCO GI

01:25

FDA Approves Daiichi Sankyo datopotamab / Datroway for Advanced Breast Cancer - Key Trial Data

01:43

Breast Cancer Eli Lilly Imlunestrant EMBER-3 Trial Results - Expert Analysis SABCS

04:30

Trastuzumab Combo: Fail or Savior for HER2+ Stomach Cancer? The EORTC-1203 'INNOVATION' Mixed Result

01:39

Does Nivolumab and Ipilimumab Combo Outshine Traditional Chemo in Colorectal Cancer?" CheckMate-8HW

02:22

Why Pamrevlumab failed in Pancreatic Cancer? Unpacking Precision Promise Trial Results ASCO GI

05:26

Short Interval ctDNA Testing Rapid Monitoring of Tumor Response in GI Cancer - Sakti Chakrabarti, MD

03:01

Could Immunotherapy Be Doing More Harm Than Good for Specific Biliary Cancer FGFR2 Mutations & IDH1?

13:44

The Role of Circulating Tumor DNA (ctDNA) in Colorectal Cancer Management - Pashtoon Kasi MD, MS

06:38

Is RMC-6236 the real deal or just hype? ASCO GI - Ignacio Garrido-Laguna, MD

06:15

Celecoxib / Celebrex & ctDNA in Colon Cancer CALGB Alliance / SWOG 80702 ASCO GI Jonathan Nowak, MD

04:03

Encorafenib + cetuximab (EC) BREAKWATER Study in BRAF V600E-Mutant Metastatic Colorectal Cancer

04:27

ctDNA & Trastuzumab Deruxtecan a New Frontier in Oesophagogastric Adenocarcinoma the DECIPHER Trial

02:58

Novartis Afinitor / Everolimus + Lanreotide A Significant Benefit in New Standard in GEP-NET?

01:39

Top 5 ASCO GI 2025 Abstracts

01:29

FDA Approves Sotorasib / Lumakras + Panitumumab / Vectibix for KRAS G12C Mutation Extending Survival

04:25

Breaking Barriers: Enhancing Cultural Sensitivity in Cancer Care for Black Patients - Reggie Ware

05:35

Unveiling the Layers: Supporting Underrepresented CLL Patients Through Empathy and Cultural Humility

45:19

Unheard Voices: The Emotional Toll of CLL on Black, Hispanic, and Asian Patients an AbbVie Report

14:14

BRCA Carriers Slicing Breast Cancer Odds International Study: Does Surgery Lead to Longevity Leaps?

14:38

Palbociclib / IBRANCE Revs Up Metastatic Breast Cancer in PATINA Results - SABCS - Otto Metzger, MD

08:47

CDK4/6 Inhibitors Breast Cancer Nemeses is the EBC Party Over for Real-World Dance-Off?

04:06

Metastatic Breast Cancer: Trastuzumab (Herceptin) Long-Term Remission HER2 - Aydah Al Awadhi SABCS

07:50

Atezolizumab Stumbles in Triple Negative Breast Cancer Study: SABCS 2024 Results with Charles Geyer

16:34

Niraparib vs. Placebo ctDNA Surveillance in High-Risk Breast Cancer Patients ZEST Trial Cleans Up!

02:35

Trastuzumab Deruxtecan / ENHERTU Superior Efficacy in Breast Cancer SABCS 2024 - Aditya Bardia, MD

02:49

💥SABCS 2024💥 2 Min Update EMBER-3 Results with Slides Imlunestrant with or without Abemaciclib

10:09

🚨 SABCS 2024 EMBER-3 Trial Results | 🚨 Full Press Conference

11:38

Exploring Edetek's CONFORM Platform: A New Approach to Clinical Data Management in Oncology Trials

02:58

NATERA GALAXY Study Links ctDNA Status to Survival & Treatment Response ESMO 2024

04:10

FDA Approves KEYTRUDA /Pembrolizumab + Chemo for Mesothelioma

04:06

FDA Approves Kisqali / Ribociclib for Early High-Risk Breast Cancer ESMO 2024

02:51

ESMO 2024 Oncologists Burnout Insights

03:22

TIGIT Combo Delivers Significant Improvement in Lung Cancer Treatment at ESMO 2024

01:52

FDA Approves Atezolizumab / Tecentriq Hybreza™️ For Subcutaneous PD-L1 Cancer Immunotherapy in NSCLC

02:43

FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small Cell Lung Cancer

02:54

Nivolumab Combo Phase 3 TiNivo 2 Results + Tivozanib in RCC Presented at ESMO 2024: AVEO

03:12

FDA Approves Lazcluze Rybrevant Combo in Advanced NSCLC: Data Revealed

01:35

Breast Cancer Genetic Testing: Should All Doctors Use ctDNA? - Nathalie McDowell Johnson, MD

04:34

FDA Approves Dostarlimab / Jemperli for Endometrial Cancer Treatment - Dr Robert DeBernardo, MD

01:07

90% People Don't Know of Simple Genetic Test for Cancer - Dr. Kevin Hughes, MD

01:23

Genetic Testing Cancer, Game Changer? - Dr. Erica Giblin, MD

01:18

Will Blood Test Show Cancer? - Dr. Barry Rosen, MD

07:54

Small Cell Lung Cancer Treatment - Dr. Jacob Sands, MD

04:24

ASCO 2024 Top 3 Practice Changing Head & Neck Cancer Studies

08:28

ASCO 2024 Top 5 Myeloid Neoplasm Risk Score Questions From A 1 Million Patient Trial